Olio Labs releases study showcasing AI-driven in vivo platform can predict clinical trial outcomes

SOUTH SAN FRANCISCO, Calif., Aug. 5, 2026 /PRNewswire/ -- Olio Labs today published research showing that its preclinical in vivo platform predicts human clinical trial outcomes ranging from gastrointestinal adverse events to cardiac toxicity. Rodent studies have historically not...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.